Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ·Healthcare·Biotechnology
$1.79
+2.00%
Mkt Cap $119.19M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$11.83
Range $8.00 – $20.00
Implied Upside
+562.7%
Consensus $11.83 vs current $1.79